IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis
  • Program Overview
    IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis
    This program, which includes a CME-certified interactive video module, downloadable slides, and a ClinicalThought commentary, provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.
  • Featured content
    The 2016 American College of Rheumatology annual meeting gave us promising data on agents targeting IL-17 in psoriatic arthritis. Here’s my take on select abstracts.
    Date Posted: 2/1/2017
  • Featured content
    In this interactive, CME-certified video module, Dafna D. Gladman, MD, FRCPC, provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.
  • 1
  • 2
  • 3

Latest Content

3 of 3 Shown
3 of 3 Shown
Show 0 More
Loading...